Rituximab+Standard CHOP vs Rituximab+Bi-weekly CHOP for Untreated Stage III/IV Low-grade B-cell Lymphoma (JCOG0203)

Clinical trial NCT00147121 · COMPLETED

Trial details

NCT number: NCT00147121
Sponsor: Haruhiko Fukuda
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Lymphoma, B-Cell

Start date: 2002-09-01
Primary completion: 2010-02-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.